| Literature DB >> 26288741 |
Maeghan O'Neill1, James F Geary2, Dalen W Agnew2, Charles D Mackenzie2, Timothy G Geary1.
Abstract
The use of a microfilaricidal drug for the control of onchocerciasis and lymphatic filariasis necessitates prolonged yearly dosing. Prospects for elimination or eradication of these diseases would be enhanced by availability of a macrofilaricidal drug. Flubendazole (FLBZ), a benzimidazole anthelmintic, is an appealing candidate macrofilaricide. FLBZ has demonstrated profound and potent macrofilaricidal effects in a number of experimental filarial rodent models and one human trial. Unfortunately, FLBZ was deemed unsatisfactory for use in mass drug administration (MDA) campaigns due to its markedly limited oral bioavailability. However, a new formulation that provided sufficient bioavailability following oral administration could render FLBZ an effective treatment for onchocerciasis and LF. This study characterized the effects of FLBZ and its reduced metabolite (FLBZ-R) on filarial nematodes in vitro to determine the exposure profile which results in demonstrable damage. Adult female Brugia malayi were exposed to varying concentrations of FLBZ or FLBZ-R (100 nM-10 μM) for up to five days, after which worms were fixed for histology. Morphological damage following exposure to FLBZ was observed prominently in the hypodermis and developing embryos at concentrations as low as 100 nM following 24 h exposure. The results indicate that damage to tissues required for reproduction and survival can be achieved at pharmacologically relevant concentrations.Entities:
Keywords: Benzimidazole; Filariasis; Histology; Macrofilaricide; Reproduction
Mesh:
Substances:
Year: 2015 PMID: 26288741 PMCID: PMC4534755 DOI: 10.1016/j.ijpddr.2015.06.002
Source DB: PubMed Journal: Int J Parasitol Drugs Drug Resist ISSN: 2211-3207 Impact factor: 4.077
Fig. 1Scoring system for tissue damage observed following incubation in FLBZ (E–P) as compared to control worms (A–D). Damage was scored as mild (1), moderate (2), severe (3), or no damage (0). HYPODERMIS (h): damage was determined by observing the level of vacuolization (gray arrow) and degree of swelling in the hypodermis. Loss of integrity to the hypodermal wall was considered to be severe. Shrunken and densely staining nuclei (gray arrowhead) as compared to controls (open arrowhead) also elicited a higher damage score. INTESTINE (i): Intestinal damage was largely determined by the number, size and shape of vacuoles in the tissue. Disruption of the intestinal borders was considered to be severe damage. OOCYTES (Oo): Early embryos (including oocytes and morulae) exhibited the most damage of all the embryonic stages. Discrimination of the oocyte cell border, degree of vacuolization and nuclear abnormalities dictate the level of damage. MORULAE (m): damaged morulae exhibited loss of cellular organization. Disintegrating morulae (dm) were classified with a higher damage score. The presence of morulae remnants (rm) also factored into the score given.
Tissue damage scores associated with flubendazole exposure assessed by two methods: A. Classical histopathological survey method; B. Individual section scoring method. Scores are averages from two independent experiments.
| Treatment | Hypodermis | Intestine | Early embryos | Late embryos | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 | 48 | 72 | 24 | 48 | 72 | 24 | 48 | 72 | 24 | 48 | 72 | |
| Control | 0.2 | 0.1 | 0.3 | 0.0 | 0.0 | 0.1 | 0.6 | 0.6 | 0.2 | 0.3 | 0.4 | 0.1 |
| 100 nM | 0.9 | 0.4 | 1.1 | 0.3 | 0.3 | 0.8 | 0.8 | 1.4 | 0.4 | 0.6 | 0.2 | 0.4 |
| 1 μM | 0.3 | 0.7 | 0.4 | 0.2 | 0.3 | 0.0 | 0.5 | 1.3 | 0.5 | 0.0 | 0.0 | 0.4 |
| 10 μM | 0.9 | 0.6 | 0.9 | 0.3 | 0.2 | 0.1 | 0.6 | 0.6 | 0.9 | 0.2 | 0.0 | 0.2 |
| Control | 0.5 | 1.2 | 0.6 | 0.0 | 0.2 | 0.3 | 0.9 | 1.1 | 0.0 | 0.2 | 0.2 | 0.7 |
| 100 nM | 1.6 | 1.5 | 1.6 | 1.5 | 0.2 | 1.8 | 1.4 | 1.9 | 1.3 | 0.8 | 0.4 | 0.6 |
| 1 μM | 1.6 | 1.6 | 2.1 | 0.4 | 1.2 | 0.4 | 1.3 | 1.9 | 1.3 | 0.0 | 1.3 | 1.1 |
| 10 μM | 2.0 | 1.8 | 2.0 | 1.1 | 1.8 | 0.7 | 1.6 | 1.6 | 2.2 | 1.5 | 1.3 | 1.3 |
Fig. 2Representative damage observed following 24 h incubation in flubendazole. A and B. Hypodermis (h), 100 nM; C. Intestine (i), 100 nM; D. Oocytes (Oo), 100 nM; E. Early morulae (m), 1 μM; F. Microfilariae (mf), 10 μM (48 h). Scale bars are 15 μm.
Fig. 3Mean motility (±SD) after exposure to flubendazole or reduced flubendazole; 10 μM (light gray triangles), 1 μM (gray triangles), 100 nM (gray squares), control (0.1%DMSO; black circles).
Tissue damage scores associated with reduced flubendazole exposure assessed by two methods: A. Classical histopathological survey method; B. Individual section scoring method. Scores are averages from two independent experiments.
| Treatment | Hypodermis | Intestine | Early embryos | Late embryos | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24 | 48 | 72 | 24 | 48 | 72 | 24 | 48 | 72 | 24 | 48 | 72 | |
| Control | 0.6 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.3 | 0.2 | 0.2 | 0.0 | 0.1 |
| 100 nM | 0.3 | 0.1 | 0.0 | 0.1 | 0.4 | 0.0 | 1.4 | 0.5 | 0.9 | 0.7 | 0.3 | 0.1 |
| 1 μM | 0.5 | 0.5 | 0.8 | 0.0 | 0.0 | 0.6 | 0.8 | 0.9 | 1.1 | 0.1 | 0.4 | 0.3 |
| 10 μM | 0.6 | 0.6 | 0.6 | 0.0 | 0.1 | 0.3 | 0.2 | 0.6 | 0.9 | 0.1 | 0.0 | 0.5 |
| Control | 0.9 | 0.8 | 0.3 | 0.0 | 0.2 | 0.1 | 0.7 | 0.8 | 0.1 | 0.1 | 0.3 | 0.0 |
| 100 nM | 1.1 | 0.9 | 0.9 | 0.4 | 0.4 | 0.6 | 1.7 | 0.6 | 1.2 | 1.4 | 0.2 | 0.0 |
| 1 μM | 1.4 | 1.0 | 1.8 | 0.3 | 0.3 | 1.3 | 1.4 | 0.9 | 1.6 | 0.5 | 0.3 | 0.2 |
| 10 μM | 1.2 | 1.4 | 1.9 | 0.2 | 0.6 | 0.8 | 0.8 | 1.1 | 1.5 | 0.2 | 0.3 | 0.6 |